Cargando…

Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches

Phosphodiesterases (PDEs) have long been considered as targets for the treatment of Alzheimer's disease (AD) and a substantial body of evidence suggests that one sub-family from the super-family of PDEs, namely PDE4D, has particular significance in this context. This review discusses the role o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tibbo, Amy J., Tejeda, Gonzalo S., Baillie, George S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824677/ https://www.ncbi.nlm.nih.gov/pubmed/31642904 http://dx.doi.org/10.1042/BST20190763

Ejemplares similares

Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme
por: Tejeda, Gonzalo S., et al.
Publicado: (2020)

PDE4-Mediated cAMP Signalling
por: Fertig, Bracy A., et al.
Publicado: (2018)

Phosphodiesterase 4B: Master Regulator of Brain Signaling
por: Tibbo, Amy J., et al.
Publicado: (2020)

Reduced PDE4D7 in prostate cancer correlates with genomic downregulation within the upstream PDE4D coding region
por: Gulliver, Chloe, et al.
Publicado: (2023)

Retracted: Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling
por: Houslay, K F, et al.
Publicado: (2019)

Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation
por: Vang, Amanda G., et al.
Publicado: (2016)

Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology
por: Paes, Dean, et al.
Publicado: (2023)

PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue
por: Spadaccini, Marco, et al.
Publicado: (2017)

Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies
por: Gulliver, Chloe, et al.
Publicado: (2023)

A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice
por: Fortin, Marylène, et al.
Publicado: (2009)

PDE4 as a target in preterm labour
por: Méhats, Céline, et al.
Publicado: (2007)

Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf
por: Blair, Connor M., et al.
Publicado: (2019)

PDE4D and PDE4B Function in Distinct Subcellular Compartments in Mouse Embryonic Fibroblasts
por: Blackman, Brigitte E., et al.
Publicado: (2011)

Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)
por: Cameron, Ryan T., et al.
Publicado: (2013)

The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease
por: MacLeod, Ruth, et al.
Publicado: (2015)

Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
por: Blauvelt, Andrew, et al.
Publicado: (2023)

Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease
por: Zhang, Chen, et al.
Publicado: (2017)

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
por: Williams, Tosha, et al.
Publicado: (2020)

Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
por: Dwomoh, Louis, et al.
Publicado: (2022)

Novel PDE4 Inhibitors Derived from Chinese Medicine Forsythia
por: Coon, Tiffany A., et al.
Publicado: (2014)

Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
por: Dumbacher, Michael, et al.
Publicado: (2018)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
por: Szczypka, Marianna
Publicado: (2020)

Design, Synthesis, and Evaluation of Dihydropyranopyrazole Derivatives as Novel PDE2 Inhibitors for the Treatment of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2021)

Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease
por: García-Morales, Victoria, et al.
Publicado: (2021)

Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners
por: Houslay, Kirsty F., et al.
Publicado: (2017)

PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
por: Teich, Andrew F., et al.
Publicado: (2016)

Targeted disruption of the heat shock protein 20–phosphodiesterase 4D (PDE4D) interaction protects against pathological cardiac remodelling in a mouse model of hypertrophy
por: Martin, Tamara P., et al.
Publicado: (2014)

The CAPRA&PDE4D5/7/9 Prognostic Model Is Significantly Associated with Adverse Post-Surgical Pathology Outcomes
por: Gulliver, Chloe, et al.
Publicado: (2022)

Activation of PDE10 and PDE11
por: Jäger, Ronald, et al.
Publicado: (2011)

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
por: Lugnier, Claire
Publicado: (2022)

Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target
por: Long, Thavy, et al.
Publicado: (2017)

Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis
por: Li, Heng, et al.
Publicado: (2022)

Lie's structural approach to PDE systems
por: Stormark, Olle
Publicado: (2000)

PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast
por: Boswell-Smith, Victoria, et al.
Publicado: (2007)

Conserved expression and functions of PDE4 in rodent and human heart
por: Richter, Wito, et al.
Publicado: (2010)

The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus
por: Byrne, Ashleigh M., et al.
Publicado: (2015)

Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases
por: Omar, Faisa, et al.
Publicado: (2019)

Evaluation of PDE4 inhibition for COPD
por: Wang, Desuo, et al.
Publicado: (2006)

Molecule of the month, PDE4DIP
por: Shapshak, Paul
Publicado: (2012)

Treating COPD with PDE 4 inhibitors
por: Brown, William M
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1kvdltodaqoridne5a08r7e7p4